An educational slide show concerning the pharmaceutical industry.

2.  Brought life expectancies beyond expectations (Torrens
247)
 Improved life for many people(Torrens 247)
 Reduced sickness (Torrens 247)
 Lessened suffering (Torrens 247)
 Eradicated many diseases (Torrens 247)
 Propel society forward (Torrens 247)
 Create industrial giants (Torrens 247)

3.  1938-1953 known as “The Age of Antibiotics” (Torrens 247)
 Antibiotics and vaccines figured important in the eradication of
syphilis, diphtheria, whooping cough, polio, and measles. (Torrens
247)
 Biomedical science helped develop novel approaches to attack
infectious, chronic, and genetic diseases. (Torrens 247)
 Improvements in life expectancy due in large part to anti-infective
therapies. (Torrens 247)
 Since 1920 death rate from influenza and pneumonia has declined
to 85% (Torrens 247)

4.  Stands for Food and Drug Administration
 Governs the pharmaceutical industries
 Administers drug discovery and drug testing
 From discovery to post marketing surveillance, drug
sponsors and FDA share overriding focus to ensure that
medicines are safe and effective. (Torrens 248)
 Follow four distinct stages
 1. Preclinical safety assessment
 2. Preapproval safety assessment in humans
 3. Safety assessment during FDA regulatory review
 4. Post marketing safety surveillance
 Includes four phases

5.  Phase I: Drugs are evaluated for safety in health
volunteers in small initial trials. (Torrens 249)
 Phase II: Efficacy of the drug is the primary focus of
these second-stage trials, safety is also studied. (Torrens
249)
 Phase III: Large trials evaluate safety and efficacy in
groups of patients with the disease to be treated. (Torrens
249)
 Phase IV: Continual surveillance of drug out in market.
(Torrens 249)

6.  Capable of making cheap generic drugs. (ehow 1)
 Market share of generic drugs were between 42 and 58 percent in
2006 due to pharmaceutical drug costs. (ehow 1)
 Pharmacy industries employ nearly 300,000 in the United States
alone. (ehow 1)
 Increase the need for education, creating more jobs. (ehow 1)

7. Disadvantages include:
 Advertising costs (Torrens 250)
 Promotional claims (side effects, purposes, contradictions
and effectiveness) ( Torrens 250)
 Labeling (right doses, directions, and warnings)
 Investigational research for safety (Torrens 250)
 Money needed to put drug out onto market and mass
produce (Torrens 250)

8.  Cheaper than brand name drugs
 Nearly bioequivalent in (Patientsabout 1)
 1. Dosage strength
 2. Safety
 3. Route of administration
 4. Quality
 5. Performance characteristics
 6. Intended use

9.  Underlying challenge is the search for a new business model
(Bowe 2)
 Model that has been used up until now was 50 years old (Bowe 2)
 Growth areas are not what they used to be (Bowe 3)
 Pharmaceutical markets are built for the old business instead of
the new (Bowe 3)

10.  Prices of medication are higher in the US than any where
else (power point Kemp)
 Medicines are checked for more safety than anywhere else
(Torrens 248)
 U.S. Companies research expenditures accumulate to 53%
compared to the rest of the world (Torrens 251)
 FDA usually completes its review of a “standard” drug in
10 to 12 months (Torrens 249)

11.  New drugs and innovations are in store in several
fields(Cbo.gov 2-3)
 FDA will continue to oversee all new drugs and
modifications (Cbo.gov 2-3)
 Prices of drugs will fluctuate with the economic swings and
insurance available (Torrens 257)
 Focus on promoting solutions will improve quality to better
results for patients and more affordable medical care
(Torrens 257)

12.  In Conclusion is the pharmaceutical industry looking
bright towards the future of America?
 The pharmaceutical industry will continue to grow and
provide both brand name and cheap generic drugs
and will be covered by several insurances including
Medicaid and Medicare and quite possibly “The
Affordable Care Act”, likewise the FDA will check all
modified/new drugs for the future.
 All things considered drugs and new technologies in
the medical field will always be apart of the United
States and will follow the fluctuations of our economy
and the new items that will be present in the near
future.

13.  Christ, S. (2012). The Benefits of Pharmaceutical Industry. Retrieved from
Http://WWW.ehow.com/list_6710523_benefits-pharmaceutical-industry.html
 Williams, S.J. and Torrens, P.R. (2008). Introduction to health Services (7th ed).
Clifton Park, NY: Thompson Delmar Learning.
 Kemp, R. Why Prescription drugs are Higher in the USA retrieved from
http://dx.doi.org/10.1136/bmj.d4584
 Kemp, R. Pharmaceutical Industry. [PowerPoint]. Retrieved from
http://dx.doi.org/10.doi.org/10.1136/bmj.d4584
 Christopher Bowe . www.forum.com. Interview with Christopher Bowe. Retrieved
October 3, 2013 from Url
http://www.forum.com/downloads/pdf/Primary-Challenges-Pharmaceutical-
Industry-Interview.pdf
 Donald B. Mary. www.cbo.gov. Current State of the pharmaceutical industry.
Retrieved October 3, 2013. From
www.http://www.cbo.gov/sites/default/files/cbofiles/ftpdocs/76xx/doc7615/1
0-02-drugr-d.pdf
 Trisha Torrey . About.com. The Pros and Cons of the Pharmaceutical Industry.
Retrieved on October 3, 2013. From
http://patients.about.com/od/drugsandsafety/a/genericdrugs.htm